[1]
Pasquini Neto, R. et al. 2022. Autologous Anti-CD19 CAR T-Cells immunotherapy in relapsed/refractory acute lymphoblastic leukemia patients. A systematic review and meta-analysis. Revista de Medicina. 101, 5 (set. 2022), e-181721. DOI:https://doi.org/10.11606/issn.1679-9836.v101i5e-181721.